<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2017-11-22" version="186">
<accession>Q13882</accession>
<accession>B2RCR3</accession>
<accession>B4DW46</accession>
<accession>Q58F01</accession>
<name>PTK6_HUMAN</name>
<protein>
<recommendedName>
<fullName>Protein-tyrosine kinase 6</fullName>
<ecNumber evidence="12 28 29">2.7.10.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Breast tumor kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase BRK</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PTK6</name>
<name type="synonym">BRK</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="2383" last="2390">
<title>Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours.</title>
<authorList>
<person name="Mitchell P.J."/>
<person name="Barker K.T."/>
<person name="Martindale J.E."/>
<person name="Kamalati T."/>
<person name="Lowe P.N."/>
<person name="Page M.J."/>
<person name="Gusterson B.A."/>
<person name="Crompton M.R."/>
</authorList>
<dbReference type="PubMed" id="8036022"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Mammary tumor</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="1497" last="1502">
<title>Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk.</title>
<authorList>
<person name="Mitchell P.J."/>
<person name="Barker K.T."/>
<person name="Shipley J."/>
<person name="Crompton M.R."/>
</authorList>
<dbReference type="PubMed" id="9333026"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201292"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1998" name="Mol. Cells" volume="8" first="401" last="407">
<title>Exon-intron structure of the human PTK6 gene demonstrates that PTK6 constitutes a distinct family of non-receptor tyrosine kinase.</title>
<authorList>
<person name="Lee H.-Y."/>
<person name="Kim M."/>
<person name="Lee K.-H."/>
<person name="Kang K.-N."/>
<person name="Lee S.-T."/>
</authorList>
<dbReference type="PubMed" id="9749526"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Melanocyte</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Urinary bladder</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="30956" last="30963">
<title>Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor.</title>
<authorList>
<person name="Kamalati T."/>
<person name="Jolin H.E."/>
<person name="Mitchell P.J."/>
<person name="Barker K.T."/>
<person name="Jackson L.E."/>
<person name="Dean C.J."/>
<person name="Page M.J."/>
<person name="Gusterson B.A."/>
<person name="Crompton M.R."/>
</authorList>
<dbReference type="PubMed" id="8940083"/>
<dbReference type="DOI" id="10.1074/jbc.271.48.30956"/>
</citation>
<scope>CHARACTERIZATION</scope>
<scope>INTERACTION WITH EGFR</scope>
<scope>MUTAGENESIS OF LYS-219 AND TYR-447</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1997" name="Int. J. Cancer" volume="71" first="1061" last="1065">
<title>Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma.</title>
<authorList>
<person name="Easty D.J."/>
<person name="Mitchell P.J."/>
<person name="Patel K."/>
<person name="Florenes V.A."/>
<person name="Spritz R.A."/>
<person name="Bennett D.C."/>
</authorList>
<dbReference type="PubMed" id="9185712"/>
<dbReference type="DOI" id="10.1002/(SICI)1097-0215(19970611)71:6&lt;1061::AID-IJC24>3.0.CO;2-F"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="4273" last="4282">
<title>A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK.</title>
<authorList>
<person name="Mitchell P.J."/>
<person name="Sara E.A."/>
<person name="Crompton M.R."/>
</authorList>
<dbReference type="PubMed" id="10980601"/>
<dbReference type="DOI" id="10.1038/sj.onc.1203775"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH STAP2</scope>
<scope>MUTAGENESIS OF TRP-44; TYR-66; ARG-105 AND LYS-219</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="6114" last="6126">
<title>Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability.</title>
<authorList>
<person name="Derry J.J."/>
<person name="Richard S."/>
<person name="Valderrama Carvajal H."/>
<person name="Ye X."/>
<person name="Vasioukhin V."/>
<person name="Cochrane A.W."/>
<person name="Chen T."/>
<person name="Tyner A.L."/>
</authorList>
<dbReference type="PubMed" id="10913193"/>
<dbReference type="DOI" id="10.1128/MCB.20.16.6114-6126.2000"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT TYR-447</scope>
<scope>INTERACTION WITH KHDRBS1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="34634" last="34641">
<title>Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition.</title>
<authorList>
<person name="Qiu H."/>
<person name="Miller W.T."/>
</authorList>
<dbReference type="PubMed" id="12121988"/>
<dbReference type="DOI" id="10.1074/jbc.M203877200"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-13; TYR-61; TYR-66; TYR-114; TYR-342 AND TYR-351</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>MUTAGENESIS OF TYR-342 AND TYR-447</scope>
<scope>ENZYME REGULATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="4212" last="4220">
<title>Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells.</title>
<authorList>
<person name="Derry J.J."/>
<person name="Prins G.S."/>
<person name="Ray V."/>
<person name="Tyner A.L."/>
</authorList>
<dbReference type="PubMed" id="12833144"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206465"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="54398" last="54404">
<title>The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2.</title>
<authorList>
<person name="Haegebarth A."/>
<person name="Heap D."/>
<person name="Bie W."/>
<person name="Derry J.J."/>
<person name="Richard S."/>
<person name="Tyner A.L."/>
</authorList>
<dbReference type="PubMed" id="15471878"/>
<dbReference type="DOI" id="10.1074/jbc.M409579200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-219 AND TYR-447</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="10558" last="10572">
<title>Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.</title>
<authorList>
<person name="Chen H.Y."/>
<person name="Shen C.H."/>
<person name="Tsai Y.T."/>
<person name="Lin F.C."/>
<person name="Huang Y.P."/>
<person name="Chen R.H."/>
</authorList>
<dbReference type="PubMed" id="15572663"/>
<dbReference type="DOI" id="10.1128/MCB.24.24.10558-10572.2004"/>
</citation>
<scope>FUNCTION IN CELL MIGRATION</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF PXN</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PXN</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Oral Oncol." volume="40" first="1040" last="1047">
<title>Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium.</title>
<authorList>
<person name="Petro B.J."/>
<person name="Tan R.C."/>
<person name="Tyner A.L."/>
<person name="Lingen M.W."/>
<person name="Watanabe K."/>
</authorList>
<dbReference type="PubMed" id="15509496"/>
<dbReference type="DOI" id="10.1016/j.oraloncology.2004.05.010"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="1982" last="1991">
<title>Regulated association of protein kinase B/Akt with breast tumor kinase.</title>
<authorList>
<person name="Zhang P."/>
<person name="Ostrander J.H."/>
<person name="Faivre E.J."/>
<person name="Olsen A."/>
<person name="Fitzsimmons D."/>
<person name="Lange C.A."/>
</authorList>
<dbReference type="PubMed" id="15539407"/>
<dbReference type="DOI" id="10.1074/jbc.M412038200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF BTK</scope>
<scope>INTERACTION WITH BTK</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="28973" last="28980">
<title>An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.</title>
<authorList>
<person name="Kim H.I.E."/>
<person name="Lee S.T."/>
</authorList>
<dbReference type="PubMed" id="15961400"/>
<dbReference type="DOI" id="10.1074/jbc.M504568200"/>
</citation>
<scope>MUTAGENESIS OF TRP-184</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="38639" last="38647">
<title>Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.</title>
<authorList>
<person name="Lukong K.E."/>
<person name="Larocque D."/>
<person name="Tyner A.L."/>
<person name="Richard S."/>
</authorList>
<dbReference type="PubMed" id="16179349"/>
<dbReference type="DOI" id="10.1074/jbc.M505802200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF KHDRBS1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Oncogene" volume="24" first="5656" last="5664">
<title>Interaction between Brk kinase and insulin receptor substrate-4.</title>
<authorList>
<person name="Qiu H."/>
<person name="Zappacosta F."/>
<person name="Su W."/>
<person name="Annan R.S."/>
<person name="Miller W.T."/>
</authorList>
<dbReference type="PubMed" id="15870689"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208721"/>
</citation>
<scope>INTERACTION WITH IRS4</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Am. J. Pathol." volume="168" first="1631" last="1641">
<title>Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes.</title>
<authorList>
<person name="Kasprzycka M."/>
<person name="Majewski M."/>
<person name="Wang Z.J."/>
<person name="Ptasznik A."/>
<person name="Wysocka M."/>
<person name="Zhang Q."/>
<person name="Marzec M."/>
<person name="Gimotty P."/>
<person name="Crompton M.R."/>
<person name="Wasik M.A."/>
</authorList>
<dbReference type="PubMed" id="16651629"/>
<dbReference type="DOI" id="10.2353/ajpath.2006.050521"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="4904" last="4912">
<title>Identification of STAT3 as a specific substrate of breast tumor kinase.</title>
<authorList>
<person name="Liu L."/>
<person name="Gao Y."/>
<person name="Qiu H."/>
<person name="Miller W.T."/>
<person name="Poli V."/>
<person name="Reich N.C."/>
</authorList>
<dbReference type="PubMed" id="16568091"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209501"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF STAT3</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="Biochem. Biophys. Res. Commun." volume="362" first="829" last="834">
<title>Molecular dissection of the interaction between the SH3 domain and the SH2-Kinase Linker region in PTK6.</title>
<authorList>
<person name="Kim H.I.E."/>
<person name="Jung J."/>
<person name="Lee E.S."/>
<person name="Kim Y.C."/>
<person name="Lee W."/>
<person name="Lee S.T."/>
</authorList>
<dbReference type="PubMed" id="17822667"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2007.08.055"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF TRP-44</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Breast Cancer Res." volume="9" first="R79" last="R79">
<title>Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6.</title>
<authorList>
<person name="Weaver A.M."/>
<person name="Silva C.M."/>
</authorList>
<dbReference type="PubMed" id="17997837"/>
<dbReference type="DOI" id="10.1186/bcr1794"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF STAT5B</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="7779" last="7787">
<title>Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion.</title>
<authorList>
<person name="Shen C.H."/>
<person name="Chen H.Y."/>
<person name="Lin M.S."/>
<person name="Li F.Y."/>
<person name="Chang C.C."/>
<person name="Kuo M.L."/>
<person name="Settleman J."/>
<person name="Chen R.H."/>
</authorList>
<dbReference type="PubMed" id="18829532"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-08-0997"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF ARHGAP35</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Mol. Cancer Res." volume="6" first="383" last="394">
<title>Distinct functions of natural ADAM-15 cytoplasmic domain variants in human mammary carcinoma.</title>
<authorList>
<person name="Zhong J.L."/>
<person name="Poghosyan Z."/>
<person name="Pennington C.J."/>
<person name="Scott X."/>
<person name="Handsley M.M."/>
<person name="Warn A."/>
<person name="Gavrilovic J."/>
<person name="Honert K."/>
<person name="Kruger A."/>
<person name="Span P.N."/>
<person name="Sweep F.C."/>
<person name="Edwards D.R."/>
</authorList>
<dbReference type="PubMed" id="18296648"/>
<dbReference type="DOI" id="10.1158/1541-7786.MCR-07-2028"/>
</citation>
<scope>INTERACTION WITH ADAM15</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-114</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="12463" last="12468">
<title>Brk is coamplified with ErbB2 to promote proliferation in breast cancer.</title>
<authorList>
<person name="Xiang B."/>
<person name="Chatti K."/>
<person name="Qiu H."/>
<person name="Lakshmi B."/>
<person name="Krasnitz A."/>
<person name="Hicks J."/>
<person name="Yu M."/>
<person name="Miller W.T."/>
<person name="Muthuswamy S.K."/>
</authorList>
<dbReference type="PubMed" id="18719096"/>
<dbReference type="DOI" id="10.1073/pnas.0805009105"/>
</citation>
<scope>INTERACTION WITH ERBB2</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Cell. Signal." volume="21" first="1415" last="1422">
<title>BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest.</title>
<authorList>
<person name="Lukong K.E."/>
<person name="Huot M.E."/>
<person name="Richard S."/>
</authorList>
<dbReference type="PubMed" id="19439179"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2009.04.008"/>
</citation>
<scope>INTERACTION WITH SFPQ</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Biochim. Biophys. Acta" volume="1806" first="66" last="73">
<title>Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK.</title>
<authorList>
<person name="Brauer P.M."/>
<person name="Tyner A.L."/>
</authorList>
<dbReference type="PubMed" id="20193745"/>
<dbReference type="DOI" id="10.1016/j.bbcan.2010.02.003"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="236" last="245">
<title>Identification of beta-catenin as a target of the intracellular tyrosine kinase PTK6.</title>
<authorList>
<person name="Palka-Hamblin H.L."/>
<person name="Gierut J.J."/>
<person name="Bie W."/>
<person name="Brauer P.M."/>
<person name="Zheng Y."/>
<person name="Asara J.M."/>
<person name="Tyner A.L."/>
</authorList>
<dbReference type="PubMed" id="20026641"/>
<dbReference type="DOI" id="10.1242/jcs.053264"/>
</citation>
<scope>PHOSPHORYLATION OF CTNNB1</scope>
<scope>INTERACTION WITH CTNNB1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E14789" last="E14789">
<title>The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of beta-catenin.</title>
<authorList>
<person name="Brauer P.M."/>
<person name="Zheng Y."/>
<person name="Evans M.D."/>
<person name="Dominguez-Brauer C."/>
<person name="Peehl D.M."/>
<person name="Tyner A.L."/>
</authorList>
<dbReference type="PubMed" id="21479203"/>
<dbReference type="DOI" id="10.1371/journal.pone.0014789"/>
</citation>
<scope>FUNCTION (ISOFORM 2)</scope>
<scope>INTERACTION (ISOFORM 2) WITH KHDRBS1 AND CTNNB1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="29700" last="29708">
<title>Solution structure and backbone dynamics of the non-receptor protein-tyrosine kinase-6 Src homology 2 domain.</title>
<authorList>
<person name="Hong E."/>
<person name="Shin J."/>
<person name="Kim H.I."/>
<person name="Lee S.T."/>
<person name="Lee W."/>
</authorList>
<dbReference type="PubMed" id="15056653"/>
<dbReference type="DOI" id="10.1074/jbc.M313185200"/>
</citation>
<scope>STRUCTURE BY NMR OF 75-174</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2016" name="Biochem. Biophys. Res. Commun." volume="478" first="637" last="642">
<title>Crystal structure of the kinase domain of human protein tyrosine kinase 6 (PTK6) at 2.33 A resolution.</title>
<authorList>
<person name="Thakur M.K."/>
<person name="Kumar A."/>
<person name="Birudukota S."/>
<person name="Swaminathan S."/>
<person name="Tyagi R."/>
<person name="Gosu R."/>
</authorList>
<dbReference type="PubMed" id="27480927"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2016.07.121"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.33 ANGSTROMS) OF 185-446</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF LYS-219</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2017" name="Biochem. Biophys. Res. Commun." volume="482" first="1289" last="1295">
<title>Co-crystal structures of PTK6: With Dasatinib at 2.24 A, with novel imidazo[1,2-a]pyrazin-8-amine derivative inhibitor at 1.70 A resolution.</title>
<authorList>
<person name="Thakur M.K."/>
<person name="Birudukota S."/>
<person name="Swaminathan S."/>
<person name="Battula S.K."/>
<person name="Vadivelu S."/>
<person name="Tyagi R."/>
<person name="Gosu R."/>
</authorList>
<dbReference type="PubMed" id="27993680"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2016.12.030"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 185-446 IN COMPLEXES WITH INHIBITORS</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] PHE-16 AND THR-436</scope>
</reference>
<comment type="function">
<text>Non-receptor tyrosine-protein kinase implicated in the regulation of a variety of signaling pathways that control the differentiation and maintenance of normal epithelia, as well as tumor growth. Function seems to be context dependent and differ depending on cell type, as well as its intracellular localization. A number of potential nuclear and cytoplasmic substrates have been identified. These include the RNA-binding proteins: KHDRBS1/SAM68, KHDRBS2/SLM1, KHDRBS3/SLM2 and SFPQ/PSF; transcription factors: STAT3 and STAT5A/B and a variety of signaling molecules: ARHGAP35/p190RhoGAP, PXN/paxillin, BTK/ATK, STAP2/BKS. Associates also with a variety of proteins that are likely upstream of PTK6 in various signaling pathways, or for which PTK6 may play an adapter-like role. These proteins include ADAM15, EGFR, ERBB2, ERBB3 and IRS4. In normal or non-tumorigenic tissues, PTK6 promotes cellular differentiation and apoptosis. In tumors PTK6 contributes to cancer progression by sensitizing cells to mitogenic signals and enhancing proliferation, anchorage-independent survival and migration/invasion. Association with EGFR, ERBB2, ERBB3 may contribute to mammary tumor development and growth through enhancement of EGF-induced signaling via BTK/AKT and PI3 kinase. Contributes to migration and proliferation by contributing to EGF-mediated phosphorylation of ARHGAP35/p190RhoGAP, which promotes association with RASA1/p120RasGAP, inactivating RhoA while activating RAS. EGF stimulation resulted in phosphorylation of PNX/Paxillin by PTK6 and activation of RAC1 via CRK/CrKII, thereby promoting migration and invasion. PTK6 activates STAT3 and STAT5B to promote proliferation. Nuclear PTK6 may be important for regulating growth in normal epithelia, while cytoplasmic PTK6 might activate oncogenic signaling pathways.</text>
</comment>
<comment type="function">
<text>Isoform 2 inhibits PTK6 phosphorylation and PTK6 association with other tyrosine-phosphorylated proteins.</text>
</comment>
<comment type="catalytic activity">
<text evidence="9 12 28 29">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="12 18 19 20 23">Activated by EGF, NRG1 and IGF1. Inhibited by SOCS3 to phosphorylate STAT3. Stabilized in the inactive form by an association between the SH3 domain and the SH2-TK linker region. Interaction between Trp-184 within SH2-TK linker region and the catalytic domain appears essential for positive regulation of kinase activity.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="12">83 uM for ATP</KM>
<Vmax evidence="12">37 nmol/min/mg enzyme</Vmax>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="5 10 11 16 17 18 24 25 26 27 30">Interacts with GAP-A.p65 (By similarity). Interacts (via SH3 and SH2 domains) with KHDRBS1. Interacts (via SH3 and SH2 domains) with phosphorylated IRS4. Interacts with ADAM15. Interacts (via SH3 domain) with SFPQ. Interacts with EGFR and ERBB2. Interacts with STAP2. Interacts with PNX. Interacts with SFPQ. Interacts with PTK/ATK. Interacts with CTNNB1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383632"/>
<interactant intactId="EBI-1383632"/>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383632"/>
<interactant intactId="EBI-2349927">
<id>Q5JST6</id>
<label>EFHC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383632"/>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383632"/>
<interactant intactId="EBI-949824">
<id>O00471</id>
<label>EXOC5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383632"/>
<interactant intactId="EBI-719823">
<id>O14526</id>
<label>FCHO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383632"/>
<interactant intactId="EBI-517684">
<id>Q13480</id>
<label>GAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383632"/>
<interactant intactId="EBI-742808">
<id>Q5VWX1</id>
<label>KHDRBS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383632"/>
<interactant intactId="EBI-1379503">
<id>P10721</id>
<label>KIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383632"/>
<interactant intactId="EBI-307352">
<id>Q04864</id>
<label>REL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383632"/>
<interactant intactId="EBI-355453">
<id>P23246</id>
<label>SFPQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1383632"/>
<interactant intactId="EBI-957615">
<id>O00401</id>
<label>WASL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell projection</location>
<location>ruffle</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="5">Membrane</location>
</subcellularLocation>
<text>Colocalizes with KHDRBS1, KHDRBS2 or KHDRBS3, within the nucleus. Nuclear localization in epithelial cells of normal prostate but cytoplasmic localization in cancer prostate.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q13882-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q13882-2</id>
<name>2</name>
<name>ALT-PTK6</name>
<name>LambdaM5</name>
<sequence type="described" ref="VSP_042066 VSP_042067"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="13 15 21 31">Epithelia-specific. Very high level in colon and high levels in small intestine and prostate, and low levels in some fetal tissues. Not expressed in breast or ovarian tissue but expressed in high percentage of breast and ovarian cancers. Also overexpressed in some metastatic melanomas, lymphomas, colon cancers, squamous cell carcinomas and prostate cancers. Also found in melanocytes. Not expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Isoform 2 is present in prostate epithelial cell lines derived from normal prostate and prostate adenocarcinomas, as well as in a variety of cell lines.</text>
</comment>
<comment type="domain">
<text>The SH3 domain plays a major role in substrate interactions. The SH2 domain of PTK6 plays a role in protein-protein interactions, but is likely more important for the regulation of catalytic activity.</text>
</comment>
<comment type="PTM">
<text evidence="10 12 14 27">Autophosphorylated. Autophosphorylation of Tyr-342 leads to an increase of kinase activity. Tyr-447 binds to the SH2 domain when phosphorylated and negatively regulates kinase activity.</text>
</comment>
<comment type="miscellaneous">
<text evidence="29">The inhibitors bind to the ATP-binding pocket.</text>
</comment>
<comment type="similarity">
<text evidence="6">Belongs to the protein kinase superfamily. Tyr protein kinase family. BRK/PTK6/SIK subfamily.</text>
</comment>
<comment type="sequence caution" evidence="34">
<conflict type="erroneous translation">
<sequence resource="EMBL-CDS" id="BAG62908" version="1"/>
</conflict>
<text>Wrong choice of CDS.</text>
</comment>
<dbReference type="EC" id="2.7.10.2" evidence="12 28 29"/>
<dbReference type="EMBL" id="X78549">
<property type="protein sequence ID" value="CAA55295.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U61412">
<property type="protein sequence ID" value="AAC34935.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U61406">
<property type="protein sequence ID" value="AAC34935.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U61407">
<property type="protein sequence ID" value="AAC34935.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U61408">
<property type="protein sequence ID" value="AAC34935.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U61409">
<property type="protein sequence ID" value="AAC34935.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U61410">
<property type="protein sequence ID" value="AAC34935.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U61411">
<property type="protein sequence ID" value="AAC34935.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315232">
<property type="protein sequence ID" value="BAG37660.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK301364">
<property type="protein sequence ID" value="BAG62908.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121829">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC035843">
<property type="protein sequence ID" value="AAH35843.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13524.1">
<molecule id="Q13882-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS74750.1">
<molecule id="Q13882-2"/>
</dbReference>
<dbReference type="PIR" id="S49016">
<property type="entry name" value="S49016"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001243287.1">
<molecule id="Q13882-2"/>
<property type="nucleotide sequence ID" value="NM_001256358.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005966.1">
<molecule id="Q13882-1"/>
<property type="nucleotide sequence ID" value="NM_005975.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.51133"/>
<dbReference type="PDB" id="1RJA">
<property type="method" value="NMR"/>
<property type="chains" value="A=75-174"/>
</dbReference>
<dbReference type="PDB" id="2KGT">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-72"/>
</dbReference>
<dbReference type="PDB" id="5D7V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.33"/>
<property type="chains" value="A/B/C/D=185-446"/>
</dbReference>
<dbReference type="PDB" id="5DA3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=185-446"/>
</dbReference>
<dbReference type="PDB" id="5H2U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.24"/>
<property type="chains" value="A/B/C/D=185-446"/>
</dbReference>
<dbReference type="PDBsum" id="1RJA"/>
<dbReference type="PDBsum" id="2KGT"/>
<dbReference type="PDBsum" id="5D7V"/>
<dbReference type="PDBsum" id="5DA3"/>
<dbReference type="PDBsum" id="5H2U"/>
<dbReference type="ProteinModelPortal" id="Q13882"/>
<dbReference type="SMR" id="Q13882"/>
<dbReference type="BioGrid" id="111720">
<property type="interactions" value="23"/>
</dbReference>
<dbReference type="DIP" id="DIP-39785N"/>
<dbReference type="IntAct" id="Q13882">
<property type="interactions" value="29"/>
</dbReference>
<dbReference type="MINT" id="MINT-1494499"/>
<dbReference type="STRING" id="9606.ENSP00000217185"/>
<dbReference type="BindingDB" id="Q13882"/>
<dbReference type="ChEMBL" id="CHEMBL4601"/>
<dbReference type="DrugBank" id="DB05294">
<property type="generic name" value="Vandetanib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2182"/>
<dbReference type="iPTMnet" id="Q13882"/>
<dbReference type="PhosphoSitePlus" id="Q13882"/>
<dbReference type="BioMuta" id="PTK6"/>
<dbReference type="DMDM" id="8928302"/>
<dbReference type="MaxQB" id="Q13882"/>
<dbReference type="PaxDb" id="Q13882"/>
<dbReference type="PeptideAtlas" id="Q13882"/>
<dbReference type="PRIDE" id="Q13882"/>
<dbReference type="DNASU" id="5753"/>
<dbReference type="Ensembl" id="ENST00000217185">
<molecule id="Q13882-2"/>
<property type="protein sequence ID" value="ENSP00000217185"/>
<property type="gene ID" value="ENSG00000101213"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000542869">
<molecule id="Q13882-1"/>
<property type="protein sequence ID" value="ENSP00000442460"/>
<property type="gene ID" value="ENSG00000101213"/>
</dbReference>
<dbReference type="GeneID" id="5753"/>
<dbReference type="KEGG" id="hsa:5753"/>
<dbReference type="UCSC" id="uc002yfg.5">
<molecule id="Q13882-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5753"/>
<dbReference type="DisGeNET" id="5753"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000101213.6"/>
<dbReference type="GeneCards" id="PTK6"/>
<dbReference type="HGNC" id="HGNC:9617">
<property type="gene designation" value="PTK6"/>
</dbReference>
<dbReference type="HPA" id="CAB032952"/>
<dbReference type="HPA" id="HPA036070"/>
<dbReference type="HPA" id="HPA036071"/>
<dbReference type="MIM" id="602004">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13882"/>
<dbReference type="OpenTargets" id="ENSG00000101213"/>
<dbReference type="PharmGKB" id="PA33960"/>
<dbReference type="eggNOG" id="KOG0197">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118938"/>
<dbReference type="HOGENOM" id="HOG000233858"/>
<dbReference type="HOVERGEN" id="HBG008761"/>
<dbReference type="InParanoid" id="Q13882"/>
<dbReference type="KO" id="K08894"/>
<dbReference type="OMA" id="VRHYKIW"/>
<dbReference type="OrthoDB" id="EOG091G0596"/>
<dbReference type="PhylomeDB" id="Q13882"/>
<dbReference type="TreeFam" id="TF351634"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-187577">
<property type="pathway name" value="SCF(Skp2)-mediated degradation of p27/p21"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69231">
<property type="pathway name" value="Cyclin D associated events in G1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8847993">
<property type="pathway name" value="ERBB2 Activates PTK6 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849468">
<property type="pathway name" value="PTK6 Regulates Proteins Involved in RNA Processing"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849469">
<property type="pathway name" value="PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849470">
<property type="pathway name" value="PTK6 Regulates Cell Cycle"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849471">
<property type="pathway name" value="PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849472">
<property type="pathway name" value="PTK6 Down-Regulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849473">
<property type="pathway name" value="PTK6 Expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849474">
<property type="pathway name" value="PTK6 Activates STAT3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8857538">
<property type="pathway name" value="PTK6 promotes HIF1A stabilization"/>
</dbReference>
<dbReference type="SignaLink" id="Q13882"/>
<dbReference type="SIGNOR" id="Q13882"/>
<dbReference type="EvolutionaryTrace" id="Q13882"/>
<dbReference type="GeneWiki" id="PTK6"/>
<dbReference type="GenomeRNAi" id="5753"/>
<dbReference type="PRO" id="PR:Q13882"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000101213"/>
<dbReference type="CleanEx" id="HS_PTK6"/>
<dbReference type="Genevisible" id="Q13882">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0031234">
<property type="term" value="C:extrinsic component of cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0001726">
<property type="term" value="C:ruffle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016477">
<property type="term" value="P:cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071300">
<property type="term" value="P:cellular response to retinoic acid"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038128">
<property type="term" value="P:ERBB2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060575">
<property type="term" value="P:intestinal epithelial cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045926">
<property type="term" value="P:negative regulation of growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061099">
<property type="term" value="P:negative regulation of protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009968">
<property type="term" value="P:negative regulation of signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045787">
<property type="term" value="P:positive regulation of cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045742">
<property type="term" value="P:positive regulation of epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010976">
<property type="term" value="P:positive regulation of neuron projection development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042531">
<property type="term" value="P:positive regulation of tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042127">
<property type="term" value="P:regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007260">
<property type="term" value="P:tyrosine phosphorylation of STAT protein"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd10358">
<property type="entry name" value="SH2_PTK6_Brk"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR035846">
<property type="entry name" value="PTK6_SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036028">
<property type="entry name" value="SH3-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001452">
<property type="entry name" value="SH3_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00018">
<property type="entry name" value="SH3_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00452">
<property type="entry name" value="SH3DOMAIN"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00326">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50044">
<property type="entry name" value="SSF50044"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50002">
<property type="entry name" value="SH3"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<keyword id="KW-0728">SH3 domain</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<feature type="chain" description="Protein-tyrosine kinase 6" id="PRO_0000088133">
<location>
<begin position="1"/>
<end position="451"/>
</location>
</feature>
<feature type="domain" description="SH3" evidence="8">
<location>
<begin position="8"/>
<end position="72"/>
</location>
</feature>
<feature type="domain" description="SH2" evidence="7">
<location>
<begin position="78"/>
<end position="170"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="6">
<location>
<begin position="191"/>
<end position="445"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="6">
<location>
<begin position="197"/>
<end position="205"/>
</location>
</feature>
<feature type="region of interest" description="Linker">
<location>
<begin position="171"/>
<end position="190"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="6 9">
<location>
<position position="312"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="6 35 36">
<location>
<position position="219"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="12">
<location>
<position position="13"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="12">
<location>
<position position="61"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="12">
<location>
<position position="66"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="4 12">
<location>
<position position="114"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="12">
<location>
<position position="342"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="12">
<location>
<position position="351"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="10">
<location>
<position position="447"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_042066" evidence="32 33">
<original>WFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLSVRDTQAVRHYKIWRRAG</original>
<variation>AGHAGCAALQDLAACRGPAAPERGGVLPQPARACELPQGPEPVPRPAAGRALPEARA</variation>
<location>
<begin position="78"/>
<end position="134"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_042067" evidence="32 33">
<location>
<begin position="135"/>
<end position="451"/>
</location>
</feature>
<feature type="sequence variant" description="In a renal papillary sample; somatic mutation." id="VAR_041760" evidence="22">
<original>L</original>
<variation>F</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56145017." id="VAR_041761" evidence="22">
<original>A</original>
<variation>T</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strong decrease in STAP2 phosphorylation. Markedly decreased interaction between SH3 domain the linker region." evidence="11 23">
<original>W</original>
<variation>A</variation>
<location>
<position position="44"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in STAP2 phosphorylation." evidence="11">
<original>Y</original>
<variation>A</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in STAP2 phosphorylation." evidence="11">
<original>R</original>
<variation>L</variation>
<location>
<position position="105"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abrogates interaction between PTK6-domain kinase and PTK6-linker. Abrogates autophosphorylation and phosphorylation of KHDRBS1." evidence="19">
<original>W</original>
<variation>A</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity and cell transformation, and phosphorylation of STAP2." evidence="11 14 30">
<original>K</original>
<variation>M</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="28">
<original>K</original>
<variation>R</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="mutagenesis site" description="3-fold lower specific kinase activity. Decreased, but still significant, autophosphorylation. Decreased, but still significant, autophosphorylation; when associated with A-447." evidence="12">
<original>Y</original>
<variation>A</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decrease in transforming potential and increase in the kinase activity level. Decreased, but still significant, autophosphorylation; when associated with A-342." evidence="12 14 30">
<original>Y</original>
<variation>F</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="12"/>
<end position="14"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="35"/>
<end position="40"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="45"/>
<end position="50"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="56"/>
<end position="62"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="64"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="67"/>
<end position="70"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="85"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="102"/>
<end position="106"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="108"/>
<end position="112"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="114"/>
<end position="118"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="125"/>
<end position="131"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="137"/>
<end position="140"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="143"/>
<end position="147"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="148"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="162"/>
<end position="164"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="188"/>
<end position="190"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="191"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="203"/>
<end position="210"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="211"/>
<end position="213"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="214"/>
<end position="221"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="223"/>
<end position="225"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="233"/>
<end position="240"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="250"/>
<end position="254"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="256"/>
<end position="264"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="272"/>
<end position="277"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="281"/>
<end position="283"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="286"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="315"/>
<end position="317"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="318"/>
<end position="320"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="322"/>
<end position="324"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="326"/>
<end position="328"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="333"/>
<end position="336"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="339"/>
<end position="343"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="345"/>
<end position="348"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="349"/>
<end position="352"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="356"/>
<end position="361"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="366"/>
<end position="380"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="381"/>
<end position="384"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="393"/>
<end position="401"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="414"/>
<end position="423"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="428"/>
<end position="430"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="434"/>
<end position="442"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1RJA"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KGT"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5DA3"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00192"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10913193"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10980601"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12121988"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12833144"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15471878"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15509496"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15539407"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15572663"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15870689"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15961400"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16568091"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16651629"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17822667"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18296648"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18719096"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19439179"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20026641"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27480927"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27993680"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8940083"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9185712"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9333026"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000305"/>
<evidence key="35" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="27480927"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="27993680"/>
</source>
</evidence>
<sequence length="451" mass="51834" checksum="CDCAC0EE242E1BD7" modified="1996-11-01" version="1">
MVSRDQAHLGPKYVGLWDFKSRTDEELSFRAGDVFHVARKEEQWWWATLLDEAGGAVAQG
YVPHNYLAERETVESEPWFFGCISRSEAVRRLQAEGNATGAFLIRVSEKPSADYVLSVRD
TQAVRHYKIWRRAGGRLHLNEAVSFLSLPELVNYHRAQSLSHGLRLAAPCRKHEPEPLPH
WDDWERPREEFTLCRKLGSGYFGEVFEGLWKDRVQVAIKVISRDNLLHQQMLQSEIQAMK
KLRHKHILALYAVVSVGDPVYIITELMAKGSLLELLRDSDEKVLPVSELLDIAWQVAEGM
CYLESQNYIHRDLAARNILVGENTLCKVGDFGLARLIKEDVYLSHDHNIPYKWTAPEALS
RGHYSTKSDVWSFGILLHEMFSRGQVPYPGMSNHEAFLRVDAGYRMPCPLECPPSVHKLM
LTCWCRDPEQRPCFKALRERLSSFTSYENPT
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>